Dougherty & Co Upgrades Vascular Solutions (VASC) to Buy; Strong Q1 and Improved Outlook

April 25, 2012 11:07 AM EDT
Get Alerts VASC Hot Sheet
Price: $56.00 --0%

Rating Summary:
    0 Buy, 5 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Dougherty & Co upgraded Vascular Solutions (NASDAQ: VASC) from Neutral to Buy, price target raised from $11.50 to $12.50.

Analyst, Deepak Chaulagai, said, "Upgrades to Buy and raises PT based on strong Q1 operating results and an improved outlook. Our PT is based on approximately 21x our 2012 Adj. EPS plus net cash, which is in-line with the comp universe’s average multiple. We believe (our PT) valuation multiple is justified because of improved growth outlook in the vein business and stabilizing
hemostat business."

Dougherty Increasing FY12 revenue/Adj. EPS estimates from $96.0M/$0.53 to $97.4M/$0.55. We are also introducing FY13 estimates with revenue of $107.3M (+10.2%Y/Y) and Adj. EPS of $0.65 (+18.6% Y/Y).

For an analyst ratings summary and ratings history on Vascular Solutions click here. For more ratings news on Vascular Solutions click here.

Shares of Vascular Solutions closed at $10.55 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst EPS Change, Analyst EPS View, Analyst PT Change, Upgrades